Former BIO head joins Connetics
Executive Summary
Former Biotechnology Industry Organization President Carl Feldbaum joins Connetics' board of directors. Connetics CEO Thomas Wiggans is a member of BIO's executive committee and was so at the time of Feldbaum's tenure. Feldbaum was the trade group's founding president; he was succeeded by former House Energy & Commerce/Oversight Subcommittee Chairman Jim Greenwood in January 2005 (1"The Pink Sheet" July 26, 2004, p. 3)...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.